Henry Ford Health
Approved Hospital Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Intranet
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Do Not Crush
Hazardous Drugs
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Brand name products with an equivalent generic may not be available to order at Henry Ford Health. For questions, contact inpatient pharmacy.
Henry Ford Health
Approved Hospital Formulary
FormWeb QuickStart
Questions or Suggestions?
Pharmacy Intranet
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Biosimilar
Black Box Warning
Do Not Crush
Hazardous Drugs
Look Alike Sound Alike
Policy
REMS
Restricted Antimicrobials
Therapeutic Interchange
Webpage Links
Search results for:
treprostinil
treprostinil
Drug Name
Form
Strength
Clinic Use Only
Inpatient Restrictions
Outpatient Restrictions
Non-Formulary
Tyvaso
SOLUTION, INHALATION
0.6 mg/mL
Remodulin
SOLUTION, INJECTABLE
1 mg/mL; 2.5 mg/mL; 5 mg/mL; 10 mg/mL
Orenitram
TABLET, EXTENDED RELEASE, ORAL
0.125 mg; 0.25; 1 mg; 2.5 mg; 5 mg
VIEW MORE
cardiovascular agents
,
agents for pulmonary hypertension
CLASS
m00040
,
m00303
High Alert Drug
:
Policy
Last updated:
Nov. 5, 2021
Policy
Tier 1: Intravenous Prostacyclin Policy
Policy
Tier 1: Subcutaneous Treprostinil (Remodulin) Policy
Policy
Tier 1: Oral Treprostinil Diolamine (Orenitram) Policy
Micromedex
Clinical Pharmacology
FDA DailyMed